Are you Dr. Durkee-Shock?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 17 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
10 Center Dr
Bethesda, MD 20892Phone+1 301-272-0628
Summary
- Dr. Jessica Durkee-Shock, MD is a board certified pediatrician in Bethesda, Maryland. She is currently licensed to practice medicine in District of Columbia, Rhode Island, and Massachusetts.
Education & Training
University of MarylandResidency, Internal Medicine, 2013 - 2016- University of MarylandResidency, Internal Medicine/Pediatrics, 2013 - 2016
University of Maryland School of MedicineClass of 2012
Certifications & Licensure
DC State Medical License 2018 - 2024
RI State Medical License 2017 - 2018
MA State Medical License 2016 - 2017- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 46 citationsRobust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency.Hannah Kinoshita, Jessica Durkee-Shock, Mariah Jensen-Wachspress, Vaishnavi V. Kankate, Haili Lang
Journal of Clinical Immunology. 2021-01-01 - 7 citationsTranscriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products.Jessica Durkee-Shock, Christopher A Lazarski, Mariah A Jensen-Wachspress, Anqing Zhang, Aran Son
Molecular Therapy. Methods & Clinical Development. 2022-06-09 - 66 citationsAntibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity.Ottavia M. Delmonte, Jenna R.E. Bergerson, Peter D. Burbelo, Jessica Durkee-Shock, Kerry Dobbs
The Journal of Allergy and Clinical Immunology. 2021-09-04
Press Mentions
As Links to MS Deepen, Researchers Accelerate Efforts to Develop an Epstein-Barr VaccineOctober 19th, 2022- SARS-CoV-2-Specific T-cell Responses Are Amplified in Children with Multisystem Inflammatory Syndrome in ChildrenAugust 27th, 2021
